Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorStephen Nicholls
About this trial
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study.
Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Eligibility criteria
Qualifiers
18 years of age
Admission for Type I myocardial infarction
Disqualifiers
LDL <1.4mmol/L at baseline
Unable to provide contact details of primary care physician/general practitioner
Unable to provide written informed consent.
Unlikely to survive >12 months
Trial design
Treatments tested in this trial
- Early Intervention
Treatment groups
2,000 Participants
are divided into 2 treatment groupsLocations
22Australia
Illawarra Shoalhaven Local Health District2500, WollongongNew South Wales, Australia
Cairns & Hinterland Hospital & Health Service4870, CairnsQueensland, Australia
Flinders Medical Centre5042, Bedford ParkSouth Australia, Australia
Monash Health3800, ClaytonVictoria, Australia
Sponsors and collaborators
Stephen Nicholls
Lead sponsor
Monash University
Sponsor institution
Amgen
Collaborator
Source ClinicalTrials.gov